If symptoms persist beyond 12 weeks despite dietary adjustments, your semaglutide formulation or dose timing should be evaluated by a PlexusDx clinician
Several case series (60) suggest that the combination of a better glycemic control, improved metabolic parameters and bodyweight reductions achieved by exenatide treatment as monotherapy or as add-on to standard therapies may lead to improvements in liver biomarkers and hepatic fat reductions in patients with T2D
The authors reported that AOD-9604 stimulated lipolysis in isolated adipocytes and that chronic daily treatment in obese Zucker rats produced reductions in body weight gain of more than 50% relative to untreated controls over the treatment period, without effects on insulin sensitivity or IGF-1 levels [3]
For example: Semaglutide for diabetes (Ozempic) typically starts at 0.25 mg weekly for 4 weeks, then 0.5 mg weekly, potentially increasing to 1 mg weekly Semaglutide for weight management (Wegovy) follows a different schedule, starting at 0.25 mg and increasing through 0.5 mg, 1.0 mg, 1.7 mg to a maintenance dose of 2.4 mg weekly For diabetes treatment, your healthcare team will typically review your HbA1c after about 3 months